VBL Therapeutics announces S-4 Registration Statement declared effective
PremiumThe FlyVBL Therapeutics announces S-4 Registration Statement declared effective
12M ago
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
Premium
Press Releases
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
12M ago
VBL Therapeutics reports Q2 EPS (1c) vs. (12c) last year
Premium
The Fly
VBL Therapeutics reports Q2 EPS (1c) vs. (12c) last year
1y ago
VBL Therapeutics close sales of manufacturing facility, assets for $7.1M
PremiumThe FlyVBL Therapeutics close sales of manufacturing facility, assets for $7.1M
1y ago
VBL Therapeutics jumps 60% after announcing merger pact with Notable Labs
Premium
The Fly
VBL Therapeutics jumps 60% after announcing merger pact with Notable Labs
2y ago
VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
Premium
Press Releases
VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
2y ago
VBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
PremiumPress ReleasesVBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
2y ago
VBL Therapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Premium
Press Releases
VBL Therapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
2y ago
VBL Therapeutics Announces Second Quarter 2022 Financial Results and Corporate Process to Explore Strategic Options
Premium
Press Releases
VBL Therapeutics Announces Second Quarter 2022 Financial Results and Corporate Process to Explore Strategic Options
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100